Integra Lifesciences Holdings (IART) Amortizatization of Intangibles (2011 - 2026)
Integra Lifesciences Holdings (IART) reported Amortizatization of Intangibles of $995000.0 for Q1 2026, down 28.16% on a YoY basis from $1.4 million in Q1 2025, and down 1.97% sequentially from $1.0 million in Q4 2025.
Integra Lifesciences Holdings (IART) Amortizatization of Intangibles (2011 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 14 years of Amortizatization of Intangibles data on file, last reported at $995000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 28.16% year-over-year to $995000.0; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 6.54% YoY), and the FY2025 full-year result was $5.6 million, changed 0.21% from the prior year.
- Amortizatization of Intangibles slipped to $995000.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.9 million in Q1 2023 to a low of $995000.0 in Q1 2026.
- A 5-year average of $1.5 million and a median of $1.4 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles increased 29.45% in 2025 and declined 28.16% in 2026, its largest moves.
- Tracing IART's Amortizatization of Intangibles over 5 years: stood at $1.7 million in 2022, then dropped by 15.85% to $1.4 million in 2023, then dropped by 2.3% to $1.4 million in 2024, then retreated by 27.5% to $1.0 million in 2025, then slipped by 1.97% to $995000.0 in 2026.
- Business Quant data shows IART's Amortizatization of Intangibles at $995000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.23 Bn | 216.98 Mn | 995,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 995,000.00 |
| Mar 31, 2026 | 995,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Dec 31, 2023 | 1.43 Mn |